Early research (Phase 1)Study completedNCT01671020
What this trial is testing
Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects
Who this might be right for
Healthy
Boryung Pharmaceutical Co., Ltd 16